These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29444744)

  • 21.
    Li Y; Lin S; Li L; Tang Z; Hu Y; Ban X; Zeng T; Zhou Y; Zhu Y; Gao S; Deng W; Zhang X; Xie D; Yuan Y; Huang P; Li J; Cai Z; Guan XY
    Cancer Res; 2018 Aug; 78(16):4471-4481. PubMed ID: 29967258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monomethyltransferase SET8 facilitates hepatocellular carcinoma growth by enhancing aerobic glycolysis.
    Chen X; Ding X; Wu Q; Qi J; Zhu M; Miao C
    Cell Death Dis; 2019 Apr; 10(4):312. PubMed ID: 30952833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
    Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
    Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
    Jia YY; Zhao JY; Li BL; Gao K; Song Y; Liu MY; Yang XJ; Xue Y; Wen AD; Shi L
    Oncotarget; 2016 Jun; 7(23):35257-69. PubMed ID: 27153552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
    Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
    Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
    Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.
    Fan J; Shan C; Kang HB; Elf S; Xie J; Tucker M; Gu TL; Aguiar M; Lonning S; Chen H; Mohammadi M; Britton LM; Garcia BA; Alečković M; Kang Y; Kaluz S; Devi N; Van Meir EG; Hitosugi T; Seo JH; Lonial S; Gaddh M; Arellano M; Khoury HJ; Khuri FR; Boggon TJ; Kang S; Chen J
    Mol Cell; 2014 Feb; 53(4):534-48. PubMed ID: 24486017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery.
    Han Z; Gorbatyuk M; Thomas J; Lewin AS; Srivastava A; Stacpoole PW
    Mitochondrion; 2007 Jul; 7(4):253-9. PubMed ID: 17392036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.
    Hong SM; Lee YK; Park I; Kwon SM; Min S; Yoon G
    J Biol Chem; 2019 May; 294(19):7810-7820. PubMed ID: 30923124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
    Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
    J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
    Liu Y; Zhao Y; Guo L
    Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma.
    Ding L; Liang X
    Ann Hepatol; 2021; 23():100307. PubMed ID: 33434687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
    Yang W; Liu J; Hou L; Chen Q; Liu Y
    Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation.
    Jin Y; Cai Q; Shenoy AK; Lim S; Zhang Y; Charles S; Tarrash M; Fu X; Kamarajugadda S; Trevino JG; Tan M; Lu J
    Oncotarget; 2016 May; 7(18):25113-24. PubMed ID: 26848621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
    Huang X; Gan G; Wang X; Xu T; Xie W
    Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.